Invenomic Capital Management’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Sell |
4,643,175
-1,793,457
| -28% | -$16M | 2.35% | 3 |
|
|
2025
Q1 | $56.1M | Buy |
6,436,632
+3,176,201
| +97% | +$27.7M | 2.83% | 1 |
|
|
2024
Q4 | $40.6M | Sell |
3,260,431
-499,112
| -13% | -$6.21M | 1.93% | 4 |
|
|
2024
Q3 | $43.6M | Sell |
3,759,543
-531,051
| -12% | -$6.17M | 2.4% | 4 |
|
|
2024
Q2 | $45.6M | Buy |
4,290,594
+338,279
| +9% | +$3.6M | 2.22% | 5 |
|
|
2024
Q1 | $47.2M | Sell |
3,952,315
-1,860,565
| -32% | -$22.2M | 2.51% | 3 |
|
|
2023
Q4 | $63M | Sell |
5,812,880
-1,139,765
| -16% | -$12.3M | 2.87% | 1 |
|
|
2023
Q3 | $68.6M | Buy |
6,952,645
+1,388,362
| +25% | +$13.7M | 2.88% | 3 |
|
|
2023
Q2 | $55.5M | Buy |
5,564,283
+1,661,373
| +43% | +$16.6M | 2.81% | 3 |
|
|
2023
Q1 | $37.5M | Buy |
3,902,910
+1,935,438
| +98% | +$18.6M | 2.12% | 11 |
|
|
2022
Q4 | $21.9M | Buy |
1,967,472
+914,106
| +87% | +$10.2M | 1.49% | 18 |
|
|
2022
Q3 | $8.98M | Buy |
+1,053,366
| New | +$8.98M | 0.77% | 46 |
|
|
2021
Q1 | – | Sell |
-110,657
| Closed | -$2.07M | – | 151 |
|
|
2020
Q4 | $2.07M | Buy |
110,657
+15,538
| +16% | +$291K | 0.53% | 28 |
|
|
2020
Q3 | $1.41M | Sell |
95,119
-10,136
| -10% | -$150K | 0.78% | 35 |
|
|
2020
Q2 | $1.69M | Hold |
105,255
| – | – | 1.25% | 25 |
|
|
2020
Q1 | $1.57M | Sell |
105,255
-23,887
| -18% | -$356K | 1.28% | 23 |
|
|
2019
Q4 | $2.6M | Buy |
+129,142
| New | +$2.6M | 1.04% | 42 |
|